Finance

CG MedTech and CGBIO Showcase Korea's Spine Surgery Excellence to Global Experts

SEOUL,South Korea,Dec. 31,2024-- CG MedTech (f/k/a Innosys,CEO Ju Mi Chung),a leading Korean orthopedic implant research and manufacturing company,partnered with CGBIO to host the International Spine

01-03

SJSemi closed $700M new financing to further boost its Advanced Packaging projects

JIANGYIN,China,Dec. 31,2024-- SJ Semiconductor Corporation (hereinafter referred to as "SJSemi" or "the company") announced the efficient and successful closure of a new financing

01-03

Boqii Announces Fiscal 2025 First Half Unaudited Financial Results

SHANGHAI,Jan. 1,2025-- Boqii Holding Limited ("We," "Boqii" or the "Company") (NYSE American: BQ),a leading pet-focused platform in China,today announced its unaudited fi

01-03

MicroAlgo Inc. Develops Hybrid Classical-Quantum Algorithms to Optimize Multi-Query Problems

SHENZHEN,China,Jan. 2,2025-- MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ:MLGO),today announcedthe development of an innovative hybrid algorithm that combines the advantag

01-03

CUBE COMPLETES ACQUISITION OF THOMSON REUTERS REGULATORY INTELLIGENCE AND ODEN BUSINESSES

Acquisition delivers an expanded customer base with a deep global subject matter expertise network that further powers CUBE\'sRegBrain AI across its industry proven SaaS RegPlatform™

01-03

TESSAN Teams Up with One Tree Planted to Launch Global Tree Planting Initiative

SHELBURNE,Vt<,Dec. 25,2024--The leading charging solution provider TESSAN has announced a new initiative to plant 10,000 trees across the United States and beyond. Through its collaboration with On

01-03 TESSAN

WuKong Education Named to the 2025 GSV 150 for Leading the Way in Education Technology

MOUNTAIN VIEW,Calif.,Dec. 24,2024--WuKong Education,a leading online K-12 education provider,has been named to the highly-anticipated 2025 edition of theGSV 150: GSV\'s annual list of the top 150 priv

01-03 WuKong Education

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS

NANTONG and SUZHOU,China,Dec. 24,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies,today announced the successful dosing of th

01-03 Ractigen Therapeutics

Xinjiang Kashgar distribution grid achieves "minute-level self-healing" for the first time

KASHGAR,China,Dec. 25,2024--On December 23,the State GridKashgar Power Supply Company successfully implemented the operation of accurate isolation of fault areas and rapid restoration of power supply

01-03 State Grid Kashgar Power Supply Company

Fangzhou Inc. Honored as an "Outstanding Innovation Firm" by Yangcheng Evening News

GUANGZHOU,China,Dec. 27,2024-- Fangzhou Inc.("Fangzhou" or the "Company") (06086.HK),a leader in Internet healthcare solutions,was honored as an "Outstanding Innovation Firm&

01-03 Fangzhou Inc.